BioAtla
(NASDAQ:BCAB)
2.31
0.04[1.76%]
At close: May 20
2.31
00
After Hours: 4:00PM EDT
Day High/Low2.16 - 2.36
52 Week High/Low2.01 - 51.83
Open / Close2.31 / 2.31
Float / Outstanding26.5M / 37.4M
Vol / Avg.321.6K / 752.6K
Mkt Cap86.4M
P/E-
50d Avg. Price4.02
Div / Yield-
Payout Ratio-
EPS-0.65
Total Float26.5M

BioAtla (NASDAQ:BCAB), Quotes and News Summary

BioAtla (NASDAQ: BCAB)

Day High/Low2.16 - 2.36
52 Week High/Low2.01 - 51.83
Open / Close2.31 / 2.31
Float / Outstanding26.5M / 37.4M
Vol / Avg.321.6K / 752.6K
Mkt Cap86.4M
P/E-
50d Avg. Price4.02
Div / Yield-
Payout Ratio-
EPS-0.65
Total Float26.5M
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise Mecbotamab vedotin, Ozuriftabmab vedotin, BA3071, and Bispecific antibody programs.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-12
REV
Q1 2022Est.ActualSurprise
EPS-0.670
REV370.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

BioAtla Questions & Answers

Q
How do I buy BioAtla (BCAB) stock?
A

You can purchase shares of BioAtla (NASDAQ: BCAB) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are BioAtla's (BCAB) competitors?
A

There are no as such competitors for BioAtla.

Q
What is the target price for BioAtla (BCAB) stock?
A

The latest price target for BioAtla (NASDAQ: BCAB) was reported by Credit Suisse on Thursday, May 5, 2022. The analyst firm set a price target for 5.00 expecting BCAB to rise to within 12 months (a possible 116.45% upside). 3 analyst firms have reported ratings in the last year.

Q
Current Stock Price for BioAtla (BCAB)?
A

The stock price for BioAtla (NASDAQ: BCAB) is $2.31 last updated May 20, 2022, 8:00 PM UTC.

Q
Does BioAtla (BCAB) pay a dividend?
A

There are no upcoming dividends for BioAtla.

Q
When is BioAtla (NASDAQ:BCAB) reporting earnings?
A

BioAtla’s Q2 earnings are confirmed for Friday, August 12, 2022.

Q
Is BioAtla (BCAB) going to split?
A

There is no upcoming split for BioAtla.

Q
What sector and industry does BioAtla (BCAB) operate in?
A

BioAtla is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.